Context: Despite the tremendous increase in the number of antihypertensive agents available, extremely limited data regarding their use in pediatric patients (pts) exists.

Objective: To determine the dosing parameters, efficacy and safety of the second generation CCB, amlodipine, in the treatment of secondary hypertension(HTN) in children.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD